PT Jayamas Medica Industri Tbk
OMED.JK
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.1T
Close$
Share Statistics
| Market cap | $6.10 Trillion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $4.08 (1.81%) |
| Earnings per Share | $13.57 |
| Beta | 0.45 |
| Outstanding Shares | 27,008,120,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 14.12 |
|---|---|
| PEG | 28.5 |
| Price to Sales | 2.66 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$594.55 B
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$593.05 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PT Jayamas Medica Industri Tbk
1,340 employees
CEO: Herlien Sri Ariani Operating under its OneMed brand, PT Jayamas Medica Industri Tbk specializes in the production and distribution of a diverse array of medical devices and supplies. The company's reach extends across Indonesia, Asia, the United States, So...